H Lee Moffitt Cancer Center & Research Institute I
12902 Magnolia Dr, Tampa, FL, 33612 · (813) 979-3054
$2.45B
Net patient revenue, FY 2025
$2.45B
Net patient revenue, FY 2025
Beds
345
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$2.45B
FY 2025
Net income
$452.9M
Patient care margin 12.0%
Discharges
12,574
Occupancy 63.5%
Clinicians
1,404
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
Zoom and drag the map, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.45B | $2.16B | 12.0% | $452.9M | 12,574 | - | 29.6% | 1.3% |
| 2024 | $2.13B | $1.84B | 13.3% | $402.0M | 11,413 | $123K | 30.4% | 0.9% |
| 2023 | $1.91B | $1.60B | 16.0% | $402.3M | 10,892 | $103K | 29.2% | 0.9% |
| 2022 | $1.67B | $1.40B | 16.3% | $343.8M | 10,327 | $174K | 32.4% | 1.3% |
| 2021 | $1.45B | $1.22B | 15.6% | $296.0M | 10,272 | $363K | 32.5% | 1.8% |
| 2020 | $1.27B | $1.07B | 16.2% | $288.0M | 9,392 | $329K | 33.5% | 2.6% |
Hospital profile
- Medicare certification number (CCN)
- 100271
- Organization NPI
- 1780653618
- Legal name
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
- County
- Hillsborough County, FL
- Ownership
- Nonprofit (private)
- Teaching
- Limited teaching
- In Medicare since
- 1986
- Full-time employees
- 5,540
- Health system
- Independent
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other hospitals in Tampa
Similar short-term acute care hospitals in Florida
Closest in number of beds
| Hospital | Place | Beds |
|---|---|---|
| HCA Florida Osceola Hospital | Kissimmee, FL | 345 |
| HCA Florida Oak Hill Hospital | Brooksville, FL | 349 |
| Hialeah Hospital | Hialeah, FL | 340 |
| Adventhealth Ocala | Ocala, FL | 351 |
| HCA Florida Orange Park Hospital | Orange Park, FL | 339 |
| Delray Medical Center | Delray Beach, FL | 352 |
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5372 Level 2 Urology and Related Services | 3,022 | 946 | $487.90 | $502.15 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 1,818 | 1,280 | $2,037.58 | $2,141.49 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 1,724 | 1,561 | $1,155.96 | $1,219.56 |
| APC 5183 Level 3 Vascular Procedures | 761 | 680 | $2,295.88 | $2,405.01 |
| APC 5373 Level 3 Urology and Related Services | 574 | 449 | $1,461.23 | $1,516.28 |
| APC 5302 Level 2 Upper GI Procedures | 555 | 424 | $1,366.93 | $1,444.50 |
| APC 5374 Level 4 Urology and Related Services | 387 | 299 | $2,495.29 | $2,629.24 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 343 | 337 | $4,665.08 | $4,981.95 |
| APC 5091 Level 1 Breast/Lymphatic Surgery and Related Procedures | 289 | 277 | $2,741.08 | $2,930.15 |
| APC 8011 Comprehensive Observation Services | 260 | 233 | $1,931.70 | $2,090.36 |
| APC 5182 Level 2 Vascular Procedures | 225 | 211 | $1,148.64 | $1,204.32 |
| APC 5361 Level 1 Laparoscopy and Related Services | 195 | 190 | $4,131.76 | $4,357.80 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. | 146 | $6.6M |
| Merck Sharp & Dohme LLC | 30 | $4.2M |
| Celgene Corporation | 25 | $3.4M |
| Regeneron Pharmaceuticals, Inc. | 598 | $3.1M |
| Exelixis Inc. | 281 | $2.4M |
| Astellas US Technologies | 11 | $2.3M |
| Janssen Research & Development, LLC | 268 | $2.1M |
| E.R. Squibb & Sons, L.L.C. | 33 | $2.0M |
| AstraZeneca Pharmaceuticals LP | 20 | $1.7M |
| Iovance Biotherapeutics, Inc. | 282 | $1.4M |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.